DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 124 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,713,000 | +10.7% | 358,380 | -22.0% | 0.07% | +40.4% |
| Q1 2022 | $4,258,000 | +26.9% | 459,290 | +463.5% | 0.05% | +40.5% |
| Q1 2020 | $3,355,000 | +671.3% | 81,500 | +625.9% | 0.04% | +825.0% |
| Q3 2018 | $435,000 | -92.8% | 11,228 | -92.7% | 0.00% | -91.7% |
| Q2 2018 | $6,019,000 | +21.9% | 152,967 | -29.8% | 0.05% | +92.0% |
| Q4 2017 | $4,938,000 | +15.6% | 217,800 | -3.2% | 0.02% | +31.6% |
| Q3 2017 | $4,273,000 | – | 225,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
| Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
| Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
| Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
| BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
| AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
| ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
| Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
| EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |